Stay updated on Tisagenlecleucel in HR B-ALL Clinical Trial
Sign up to get notified when there's something new on the Tisagenlecleucel in HR B-ALL Clinical Trial page.

Latest updates to the Tisagenlecleucel in HR B-ALL Clinical Trial page
- Check3 days agoChange DetectedThe trial site list was updated to add Texas Children's Cancer and Hematology Center in Houston and a Calgary, Canada site (T3B6A8), and to remove the prior Calgary entry.SummaryDifference0.3%

- Check10 days agoChange DetectedRevision updated from v3.4.2 to v3.4.3.SummaryDifference0.0%

- Check17 days agoNo Change Detected
- Check32 days agoChange DetectedRevision updated from v3.4.1 to v3.4.2; this change does not affect study content, eligibility criteria, outcomes, or navigation. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check39 days agoChange DetectedFooter now shows Revision: v3.4.1, replacing Revision: v3.4.0.SummaryDifference0.1%

- Check54 days agoChange DetectedThe study location entry for Phoenix Children's Hospital is updated to Phoenix Childrens Hospital, and the Last Update Posted label has changed from 'Last Update Posted (Estimated)' to 'Last Update Posted' with an updated date.SummaryDifference0.2%

- Check61 days agoChange DetectedThe page revision was updated to v3.3.4, replacing v3.3.3.SummaryDifference0.0%

Stay in the know with updates to Tisagenlecleucel in HR B-ALL Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Tisagenlecleucel in HR B-ALL Clinical Trial page.